<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05071794</url>
  </required_header>
  <id_info>
    <org_study_id>PAFHIslamabad</org_study_id>
    <nct_id>NCT05071794</nct_id>
  </id_info>
  <brief_title>Effect of Propofol on Postoperative Nausea and Vomiting.</brief_title>
  <official_title>Effect of Propofol on Postoperative Nausea and Vomiting in Patients Undergoing Elective Cesarean Section Under Spinal Anesthesia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pakistan Air Force (PAF) Hospital Islamabad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pakistan Air Force (PAF) Hospital Islamabad</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      As PONV is a dreadful experience that badly affects the patients' quality of life after&#xD;
      surgery and the anti-emetic effects of propofol have been seldomly studied in Pakistan, this&#xD;
      study aims at investigation of the beneficial effects of propofol in reducing the occurrence&#xD;
      of PONV.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cesarean Section is one of the most commonly performed surgical procedures in the obstetric&#xD;
      patients. Adequate intra and postoperative analgesia is very important in providing comfort&#xD;
      to the mother, early breastfeeding, ambulation and discharge as well as enhancing patient&#xD;
      satisfaction.Spinal anesthesia is widely accepted as the anesthesia of choice for cesarean&#xD;
      section owing to its safety and speed. PONV is an unpleasant condition, often underestimated&#xD;
      side effect of anesthesia and surgery, quite common in women undergoing spinal anesthesia for&#xD;
      cesarean.It is one of the significant problems in Post Anaesthesia Care Units. The etiology&#xD;
      of PONV is multifactorial with patient factors (gender, history of motion sickness, age),&#xD;
      intra Op factors (type of anesthesia, surgery and opioid use) and post Op factors (pain, post&#xD;
      Op opioid use) which are found to be associated with the PONV.3 Apfel simplified scoring is&#xD;
      based on four independent factors including female gender, non-smoker, history of PONV or&#xD;
      motion sickness and use of opioids. Each predictor is given a score of 1. A score of 0,1,2,3&#xD;
      or 4 predicts the chance of developing PONV as approximately 10%, 20%, 40% or 80%.&#xD;
&#xD;
      The intense efforts accompanying emesis increase the risk of complications such as wound&#xD;
      dehiscence, bleeding, aspiration pneumonitis, dehydration, electrolyte imbalance and&#xD;
      interference with nutrition. While it is difficult to completely avoid the occurrence of&#xD;
      PONV, it can be markedly reduced using a multimodal non-opioid analgesia, total intravenous&#xD;
      anesthesia and adequate prophylactic antiemetic premedication.1,5 Propofol has been reported&#xD;
      to have anti-emetic effects at sub hypnotic dose as a bolus or a continuous infusion in&#xD;
      susceptible individuals undergoing surgeries, though the exact mechanism of this effect is&#xD;
      yet to be discovered.&#xD;
&#xD;
      In a research published in BMC Anesthesiology, the data indicates a significant difference in&#xD;
      the incidence of PONV in control group (93.9%) and the study group (8.7%) with a single sub&#xD;
      hypnotic dose of propofol administered 10-15 min before the end of surgery in parturients&#xD;
      undergoing cesarean section under spinal anaesthesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized clinical trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative nausea and vomiting</measure>
    <time_frame>1 hour stay in Postanaesthesia Care Unit</time_frame>
    <description>Subjective complaint of nausea or any episode of vomiting</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subhypnotic dose of propofol, 0.5mg/kg, 10 - 15 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline 0.9%, 10 mL , 10 - 15 min before end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Antiemetic effect of propofol</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>propofol injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline 0.9%</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Group B</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Parturient aged between 18 - 50 years&#xD;
&#xD;
          -  Elective Cesarean under spinal anesthesia&#xD;
&#xD;
          -  Patients at increased risk of PONV based on Apfel score 2 or more&#xD;
&#xD;
          -  ASA Class II&#xD;
&#xD;
          -  Ability to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to propofol&#xD;
&#xD;
          -  ASA Class III and above&#xD;
&#xD;
          -  Anti emetic drug administered 24 hrs prior to surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Biological</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ATIF NAZIR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PAF Hospital Islamabad</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ATIF NAZIR, MD</last_name>
    <phone>00923340572855</phone>
    <email>atifnazir656@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>PAF Hospital Islamabad</name>
      <address>
        <city>Islamabad</city>
        <state>Federal</state>
        <zip>44230</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ATIF NAZIR, MD</last_name>
      <phone>00923340572855</phone>
      <email>atifnazir656@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Niu K, Liu H, Chen RW, Fang QW, Wen H, Guo SM, Williams JP, An JX. Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial. J Anesth. 2018 Oct;32(5):748-755. doi: 10.1007/s00540-018-2549-x. Epub 2018 Sep 12.</citation>
    <PMID>30209576</PMID>
  </reference>
  <reference>
    <citation>Shaikh SI, Nagarekha D, Hegade G, Marutheesh M. Postoperative nausea and vomiting: A simple yet complex problem. Anesth Essays Res. 2016 Sep-Dec;10(3):388-396. Review.</citation>
    <PMID>27746521</PMID>
  </reference>
  <reference>
    <citation>Urits I, Orhurhu V, Jones MR, Adamian L, Borchart M, Galasso A, Viswanath O. Postoperative Nausea and Vomiting in Paediatric Anaesthesia. Turk J Anaesthesiol Reanim. 2020 Apr;48(2):88-95. doi: 10.5152/TJAR.2019.67503. Epub 2019 Nov 11. Review.</citation>
    <PMID>32259138</PMID>
  </reference>
  <reference>
    <citation>Kim EG, Park HJ, Kang H, Choi J, Lee HJ. Antiemetic effect of propofol administered at the end of surgery in laparoscopic assisted vaginal hysterectomy. Korean J Anesthesiol. 2014 Mar;66(3):210-5. doi: 10.4097/kjae.2014.66.3.210. Epub 2014 Mar 28.</citation>
    <PMID>24729843</PMID>
  </reference>
  <reference>
    <citation>Jelting Y, Klein C, Harlander T, Eberhart L, Roewer N, Kranke P. Preventing nausea and vomiting in women undergoing regional anesthesia for cesarean section: challenges and solutions. Local Reg Anesth. 2017 Aug 9;10:83-90. doi: 10.2147/LRA.S111459. eCollection 2017. Review.</citation>
    <PMID>28860857</PMID>
  </reference>
  <results_reference>
    <citation>Kampo S, Afful AP, Mohammed S, Ntim M, Buunaaim ADB, Anabah TW. Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiol. 2019 Sep 14;19(1):177. doi: 10.1186/s12871-019-0847-y.</citation>
    <PMID>31521119</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pakistan Air Force (PAF) Hospital Islamabad</investigator_affiliation>
    <investigator_full_name>Atif Nazir</investigator_full_name>
    <investigator_title>Dr Atif Nazir</investigator_title>
  </responsible_party>
  <keyword>postoperative nausea and vomiting, propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

